Condition

Philadelphia Chromosome Positive CML (3)

BCR-ABL Positive Chronic Myelogenous Leukemia (1)

Chronic Myeloid Leukemia (1)

Overall Status

Completed (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Centre Leon Berard (1)

Novartis Pharmaceuticals (1)

The University of Hong Kong (1)

Collaborator

Intervention

imatinib mesylate (2)

imatinib (1)

ponatinib (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

Philadelphia Chromosome Positive CML

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

Recruiting

Philadelphia Chromosome Positive CML
BCR-ABL Positive Chronic Myelogenous Leukemia

Amiens, France
+27 more

Dec 9, 2021

Philadelphia Chromosome Positive CML Trial in Worldwide (imatinib mesylate)

Completed

Philadelphia Chromosome Positive CML

imatinib mesylate

Chicago, Illinois
+9 more

Jun 3, 2021

Chronic Myeloid Leukemia, Philadelphia Chromosome Positive CML Trial in Hong Kong (Imatinib Mesylate)

Unknown status

Chronic Myeloid Leukemia
Philadelphia Chromosome Positive CML

Imatinib Mesylate

Hong Kong, Hong Kong

The University of Hong Kong

Aug 7, 2017